• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于细胞药物递送的纳米晶磷灰石胶体的新进展。

New advances in nanocrystalline apatite colloids intended for cellular drug delivery.

机构信息

CIRIMAT Carnot Institute, University of Toulouse, CNRS/INPT/UPS, ENSIACET, 118 route de Narbonne, 31077 Toulouse, France.

出版信息

Langmuir. 2009 Oct 20;25(20):12256-65. doi: 10.1021/la901671j.

DOI:10.1021/la901671j
PMID:19821625
Abstract

Intracellular drug delivery using colloidal biomimetic calcium phosphate apatites as nanocarriers is a seducing concept. However, the colloid preparation to an industrial scale requires the use of easily handled raw materials as well as the possibility to tailor the nanoparticles size. In this work, the stabilization of the colloids was investigated with various biocompatible agents. Most interestingly, nanoscale colloids were obtained without the need for toxic and/or hazardous raw materials. Physico-chemical characteristics were investigated by chemical analyses, dynamic light scattering, FTIR/Raman spectroscopies, XRD, and electron microscopy. A particularly promising colloidal system associates biomimetic apatite stabilized with a natural phospholipid moiety (AEP(r), 2-aminoethylphosphoric acid). Complementary data described such colloids as apatite nanocrystals covered with surface Ca(2+)(AEP(r)(-))(2) complexes involving "supernumerary" Ca(2+) ions. The effects of the concentration in AEPr, synthesis temperature, duration of aging in solution, pH, and sonication were followed, showing that it is possible to modulate the mean size of the nanoparticles, typically in the range 30-100 nm. The perfect biocompatibility of such colloids allied to the possibility to prepare them from innocuous compounds shows great promise for intracellular drug delivery.

摘要

使用胶体仿生磷酸钙磷灰石作为纳米载体进行细胞内药物输送是一个诱人的概念。然而,将胶体制备到工业规模需要使用易于处理的原材料以及能够定制纳米颗粒尺寸的可能性。在这项工作中,用各种生物相容性试剂研究了胶体的稳定性。最有趣的是,无需使用有毒和/或危险的原材料即可获得纳米级胶体。通过化学分析、动态光散射、FTIR/Raman 光谱、XRD 和电子显微镜研究了物理化学特性。一种特别有前途的胶体系统是由仿生磷灰石与天然磷脂部分(AEP(r),2-氨基乙基磷酸)稳定的胶体。补充数据将这种胶体描述为纳米晶磷灰石,表面覆盖有 Ca(2+)(AEP(r)(-))(2) 配合物,其中涉及“多余”的 Ca(2+) 离子。研究了 AEPr 的浓度、合成温度、溶液中老化时间、pH 值和超声处理的影响,结果表明可以调节纳米颗粒的平均尺寸,通常在 30-100nm 范围内。这种胶体的完美生物相容性以及能够用无害化合物制备它们的可能性为细胞内药物输送展示了巨大的前景。

相似文献

1
New advances in nanocrystalline apatite colloids intended for cellular drug delivery.用于细胞药物递送的纳米晶磷灰石胶体的新进展。
Langmuir. 2009 Oct 20;25(20):12256-65. doi: 10.1021/la901671j.
2
Surface characteristics of nanocrystalline apatites: effect of mg surface enrichment on morphology, surface hydration species, and cationic environments.纳米晶磷灰石的表面特性:镁表面富集对形态、表面水合物种和阳离子环境的影响。
Langmuir. 2009 May 19;25(10):5647-54. doi: 10.1021/la804230j.
3
Purification of biomimetic apatite-based hybrid colloids intended for biomedical applications: A dialysis study.用于生物医学应用的仿生磷灰石基杂化胶体的纯化:透析研究。
Colloids Surf B Biointerfaces. 2011 Feb 1;82(2):378-84. doi: 10.1016/j.colsurfb.2010.09.022.
4
Mechanism and kinetics of apatite formation on nanocrystalline TiO2 coatings: a quartz crystal microbalance study.纳米晶TiO₂涂层上磷灰石形成的机制与动力学:石英晶体微天平研究
Acta Biomater. 2008 May;4(3):560-8. doi: 10.1016/j.actbio.2007.10.003. Epub 2007 Oct 22.
5
Modification of bone-like apatite nanoparticle size and growth kinetics by alizarin red S.茜素红 S 对类骨磷灰石纳米颗粒大小和生长动力学的修饰。
Nanoscale. 2010 Nov;2(11):2478-86. doi: 10.1039/c0nr00488j. Epub 2010 Oct 7.
6
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.用于基因递送的壳聚糖-三聚磷酸钠纳米颗粒的表面电荷、粒径和形态特性的调控。
Colloids Surf B Biointerfaces. 2005 Aug;44(2-3):65-73. doi: 10.1016/j.colsurfb.2005.06.001.
7
The effect of pH on the structural evolution of accelerated biomimetic apatite.pH 对加速仿生磷灰石结构演变的影响。
Biomaterials. 2004 Oct;25(22):5323-31. doi: 10.1016/j.biomaterials.2003.12.037.
8
Interaction between a bisphosphonate, tiludronate and nanocrystalline apatite: in vitro viability and proliferation of HOP and HBMSC cells.双膦酸盐替鲁膦酸与纳米磷灰石的相互作用:HOP 和 HBMSC 细胞的体外活力和增殖。
Biomed Mater. 2012 Oct;7(5):054108. doi: 10.1088/1748-6041/7/5/054108. Epub 2012 Sep 12.
9
Characterization, physicochemical properties and biocompatibility of La-incorporated apatites.镧掺杂磷灰石的表征、物理化学性质及生物相容性。
Acta Biomater. 2009 Nov;5(9):3512-23. doi: 10.1016/j.actbio.2009.05.026. Epub 2009 May 27.
10
Chitosan/apatite composite beads prepared by in situ generation of apatite or Si-apatite nanocrystals.原位生成磷灰石或硅磷灰石纳米晶制备壳聚糖/磷灰石复合珠。
Acta Biomater. 2010 Feb;6(2):466-76. doi: 10.1016/j.actbio.2009.07.029. Epub 2009 Jul 25.

引用本文的文献

1
Enhanced Drug Loading Capacity Using the Dual Metformine-Dexketoprofren Salt on Nanoapatite Materials.在纳米磷灰石材料上使用双二甲双胍-右酮洛芬盐提高药物负载能力。
Mol Pharm. 2025 Jun 2;22(6):3377-3387. doi: 10.1021/acs.molpharmaceut.5c00264. Epub 2025 Apr 24.
2
Biomineralization of bone tissue: calcium phosphate-based inorganics in collagen fibrillar organic matrices.骨组织的生物矿化:胶原纤维有机基质中基于磷酸钙的无机物。
Biomater Res. 2022 Sep 6;26(1):42. doi: 10.1186/s40824-022-00288-0.
3
Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications.
纳米羟基磷灰石介导的伊马替尼传递用于特定的抗癌应用。
Molecules. 2020 Oct 9;25(20):4602. doi: 10.3390/molecules25204602.
4
Preparation of CaP/pDNA nanoparticles by reverse micro-emulsion method: Optimization of formulation variables using experimental design.通过反向微乳液法制备磷酸钙/质粒DNA纳米颗粒:利用实验设计优化配方变量
Asian J Pharm Sci. 2017 Mar;12(2):179-186. doi: 10.1016/j.ajps.2016.09.006. Epub 2016 Nov 4.
5
Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.负载靶向肿瘤的小干扰RNA的生物相容性且经胶体稳定的甲氧基聚乙二醇-磷脂/磷酸钙杂化纳米颗粒
Oncotarget. 2016 Jan 19;7(3):2855-66. doi: 10.18632/oncotarget.6428.